Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug...
Expertise from award-winning computational biologist, human immunologist and engineer with experience from Yale, NIH, and NIAID will help advance ImmunoScape’s machine learning capabilities
ImmunoScape, a...
Funding will advance company’s two lead programs through clinical proof-of-mechanism, as well as enable continued growth of its biologics pipeline and expansion of its...
Evaxion Biotech A/S, a clinical-stage TechBio company focused on developing AI-Immunology™-powered vaccines is pleased to present its novel precision vaccine concept at the 65th...